This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Boehringer Ingelheim Animal Health USA Inc., Merial Limited. Active years: 2015-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2019
Title: Edmond Jolivet: Innovator in Antibiotic-Free Plasmids
Introduction
Edmond Jolivet is a notable inventor based in Orlienas, France. He has made significant contributions to the field of biotechnology, particularly in the development of antibiotic-free plasmids. With a total of two patents to his name, his work focuses on innovative methods that enhance the maintenance of gram-negative bacteria without the reliance on antibiotic selection pressure.
Latest Patents
Jolivet's latest patents revolve around the concept of antibiotic-free plasmids. The first patent provides a method for maintaining a gram-negative bacterium plasmid without the use of antibiotic selection pressure. This invention includes drugless plasmids that contain a heterologous gene. Additionally, it offers formulations and compositions that comprise these drugless plasmids, which can express proteins or immunogens. The invention also outlines methods for administering these formulations to a host, emphasizing the potential applications in medical and agricultural fields.
Career Highlights
Throughout his career, Edmond Jolivet has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Boehringer Ingelheim Animal Health USA Inc. and Merial Limited. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field of animal health and biotechnology.
Collaborations
Jolivet has collaborated with several professionals in his field, including Jean-Christophe Francis Audonnet. These collaborations have likely enriched his research and development efforts, leading to advancements in his patented technologies.
Conclusion
Edmond Jolivet's work in antibiotic-free plasmids represents a significant advancement in biotechnology. His innovative methods and formulations have the potential to transform practices in both medical and agricultural applications. His contributions continue to influence the field, showcasing the importance of innovation in addressing contemporary challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile